SCHEMBL3130869

SCHEMBL3130869

Fc1ccccc1Cc1cc2ccccc2cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.49
PDE10A Q9Y233 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.44
ATM Q13315 1/20 0.44
CYP1A2 P05177 1/20 0.40
CYP2A6 P11509 1/20 0.40
PDPK1 O15530 1/20 0.40
MDM2 Q00987 1/20 0.40
HTR2C P28335 1/20 0.40
HTR2B P41595 1/20 0.40
ALDH1A1 P00352 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
KDM4E B2RXH2 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
CYP3A4 P08684 3/20 0.38
CYP2D6 P10635 3/20 0.38
SLC6A2 P23975 3/20 0.38
SLC6A4 P31645 3/20 0.38
SLC6A3 Q01959 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3125030 0.85 MDM2 (0.46) NPC1PDE10AL3MBTL1ATMCYP1A2
SCHEMBL3128182 0.81 PDE10A (0.52) PDE10AL3MBTL1ATMCYP1A2CYP2A6
SCHEMBL3119753 0.79 PDE10A (0.48) PDE10AL3MBTL1ATMCYP1A2CYP2A6
SCHEMBL14997327 0.76 PDE10A (0.45) NPC1PDE10AL3MBTL1ATMCYP1A2
SCHEMBL3121339 0.74 HTR2B (0.50) PDE10AL3MBTL1ATMCYP1A2CYP2A6
SCHEMBL3823640 0.74 ATM (0.51) NPC1PDE10AL3MBTL1ATMCYP1A2
SCHEMBL3121450 0.73 HTR2C (0.42) NPC1PDE10AL3MBTL1ATMHTR2C
SCHEMBL17664090 0.73 NPC1 (0.40) NPC1PDE10AL3MBTL1ATMCYP1A2
SCHEMBL17664092 0.72 HSP90AB1 (0.47) PDE10AL3MBTL1ATMCYP1A2CYP2A6
SCHEMBL20097380 0.72 TAAR1 (0.46) NPC1L3MBTL1HTR2CHTR2BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2143714-B1 TETRAHYDROISOQUINOLINE COMPOUND KOWA CO (JP) 2013-06-05 EP disclosed
EP-2143714-B1 TETRAHYDROISOQUINOLINE COMPOUND KOWA CO (JP) 2013-06-05 EP disclosed
US-8273766-B2 Tetrahydroisoquinoline compound KOWA COMPANY, LTD. (JP) 2012-09-25 US disclosed
US-8273766-B2 Tetrahydroisoquinoline compound KOWA COMPANY, LTD. (JP) 2012-09-25 US disclosed
US-8273766-B2 Tetrahydroisoquinoline compound KOWA COMPANY, LTD. (JP) 2012-09-25 US disclosed
US-20100120844-A1 TETRAHYDROISOQUINOLINE COMPOUND KOWA COMPANY, LTD. (JP) 2010-05-13 US disclosed
US-20100120844-A1 TETRAHYDROISOQUINOLINE COMPOUND KOWA COMPANY, LTD. (JP) 2010-05-13 US disclosed
US-20100120844-A1 TETRAHYDROISOQUINOLINE COMPOUND KOWA COMPANY, LTD. (JP) 2010-05-13 US disclosed
EP-2143714-A1 TETRAHYDROISOQUINOLINE COMPOUND Kowa Company, Ltd. (JP) 2010-01-13 EP disclosed
EP-2143714-A1 TETRAHYDROISOQUINOLINE COMPOUND Kowa Company, Ltd. (JP) 2010-01-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120844-A1 TETRAHYDROISOQUINOLINE COMPOUND CCR3, CCR5, CCR1 NPC1 266/4885PDE10A 2363/4885L3MBTL1 4241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.